NYSE · Healthcare
ALPHA PRO TECH LTD (APT)
As-reported financials and recent SEC filings for ALPHA PRO TECH LTD, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$59.1M
Net income
$3.5M
Net margin
6.0%
Diluted EPS
$0.33
ROE
5.7%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $59.1M | $57.8M | $61.2M | $62.0M | $68.6M |
| Gross profit | $22.5M | $22.9M | $22.8M | $21.7M | $25.3M |
| Operating income | $3.8M | $3.4M | $4.1M | $4.7M | $7.9M |
| Net income | $3.5M | $3.9M | $4.2M | $3.3M | $6.8M |
| Diluted EPS | $0.33 | $0.35 | $0.35 | $0.26 | $0.50 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-15
View on EDGAR →42026-05-19
View on EDGAR →42026-05-18
View on EDGAR →1442026-05-14
View on EDGAR →42026-05-13
View on EDGAR →10-Q2026-05-07
View on EDGAR →8-K2026-05-07
View on EDGAR →DEFA14A2026-04-30
View on EDGAR →Largest Healthcare peers
Go deeper on APT
Search ALPHA PRO TECH LTD’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.